» Articles » PMID: 23097747

Inhibition of Catalytic Activities of Botulinum Neurotoxin Light Chains of Serotypes A, B and E by Acetate, Sulfate and Calcium

Overview
Specialty Biochemistry
Date 2012 Oct 26
PMID 23097747
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The catalytic domain, known as light chain (Lc), of the most poisonous botulinum neurotoxins (BoNTs), possesses endoprotease activity that triggers the ultimate poisonous effect to animals and humans. X-ray crystallographic structure of Lc of several BoNT serotypes has identified at least four small ligands at or near the respective active sites. They are sulfate ions in LcA, LcB, and LcE; an acetate ion in LcA; a calcium ion in LcB; and a potassium ion in LcD. Roles of these ligands on the structure and function of the proteins are not known. We have investigated the roles of sulfate, acetate, and calcium on the catalytic activities of LcA, LcB, and LcE using 17-35-residue synthetic peptide substrates. All three ligands inhibited all Lc activities. For LcA and LcB, the order of inhibition effectiveness was calcium>sulfate>acetate. The inhibition effectiveness expressed as IC(50), did not correlate with the occurrence or proximity of the ions to the active site. Moreover, addition of acetate or sulfate to LcA did not affect the near-UV circular dichroism spectra, tryptophan, and tyrosine fluorescence spectra, and mid points of thermal denaturation of LcA. Our results suggest that acetate, sulfate, and calcium nonspecifically interact with BoNT Lc, and their occurrence in the crystal structures could have been due to opportunistic binding to complementary pockets.

Citing Articles

Cleavage of SNAP25 and its shorter versions by the protease domain of serotype A botulinum neurotoxin.

Mizanur R, Stafford R, Ahmed S PLoS One. 2014; 9(4):e95188.

PMID: 24769566 PMC: 4000213. DOI: 10.1371/journal.pone.0095188.


Isolation and quantification of botulinum neurotoxin from complex matrices using the BoTest matrix assays.

Dunning F, Piazza T, Zeytin F, Tucker W J Vis Exp. 2014; (85).

PMID: 24638074 PMC: 4123472. DOI: 10.3791/51170.


The C terminus of the catalytic domain of type A botulinum neurotoxin may facilitate product release from the active site.

Mizanur R, Frasca V, Swaminathan S, Bavari S, Webb R, Smith L J Biol Chem. 2013; 288(33):24223-33.

PMID: 23779108 PMC: 3745367. DOI: 10.1074/jbc.M113.451286.

References
1.
Schiavo G, Rossetto O, Benfenati F, Poulain B, Montecucco C . Tetanus and botulinum neurotoxins are zinc proteases specific for components of the neuroexocytosis apparatus. Ann N Y Acad Sci. 1994; 710:65-75. DOI: 10.1111/j.1749-6632.1994.tb26614.x. View

2.
Ahmed S, McPhie P, Smith L . Autocatalytically fragmented light chain of botulinum a neurotoxin is enzymatically active. Biochemistry. 2003; 42(43):12539-49. DOI: 10.1021/bi030062c. View

3.
Foran P, Shone C, Dolly J . Differences in the protease activities of tetanus and botulinum B toxins revealed by the cleavage of vesicle-associated membrane protein and various sized fragments. Biochemistry. 1994; 33(51):15365-74. DOI: 10.1021/bi00255a017. View

4.
Agarwal R, Binz T, Swaminathan S . Analysis of active site residues of botulinum neurotoxin E by mutational, functional, and structural studies: Glu335Gln is an apoenzyme. Biochemistry. 2005; 44(23):8291-302. DOI: 10.1021/bi050253a. View

5.
Hale M, Oyler G, Swaminathan S, Ahmed S . Basic tetrapeptides as potent intracellular inhibitors of type A botulinum neurotoxin protease activity. J Biol Chem. 2010; 286(3):1802-11. PMC: 3023475. DOI: 10.1074/jbc.M110.146464. View